A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)

NCT00717860 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Fungal Infection

Interventions

DRUG: caspofungin acetate
DRUG: Comparator: Micafungin sodium

Sponsor

Merck Sharp & Dohme LLC